Excess of mortality in adults and elderly and circulation of subtypes of influenza virus in southern Brazil

Frontiers in Immunology

Volumn 8, Issue JAN, 2018, Pages

  Freitas, André Ricardo Ribas ^a   Donalisio, Maria Rita ^b  

^a Leopoldo Mandic University   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Elderly; Excess of mortality; Influenza; Influenza AH1N1; Influenza AH3N2; Pandemic; Serfling regression model

Indexed keywords

ARTICLE; DISEASE SURVEILLANCE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; INFLUENZA VACCINATION; INFLUENZA VIRUS; MORTALITY RATE; NONHUMAN; PANDEMIC; PHARYNX DISEASE; PNEUMONIA; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE;

EID: 85040116987     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01903     Document Type: Article

References (49)

1. Center for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2002) 51:1-31
2. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol (2004) 160(5):492-502. doi:10.1093/aje/kwh227
3. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 283(4):499-505. doi:10.1001/jama.283.4.499
4. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis (2006) 194(S2):S82-91. doi:10.1086/507558
5. Chiu SS, Lau YL, Chan KH, Wong WHS, Peiris JM. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med (2002) 347(26):2097-103. doi:10.1056/NEJMoa020546
6. Francisco PMSB, Donalisio MR, Marín-León L. Trends in mortality from respiratory diseases among the elderly and the influenza vaccine intervention, 1980-2009. Rev Panm Salud Publica (2013) 34(3):155-61
7. Freitas ARR, Francisco PMSB, Donalisio MR. Mortality associated with influenza in tropics, state of Sao Paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic, and post-pandemic periods. Influenza Res Treat (2013) 2013:696274. doi:10.1155/2013/696274
8. Nicoll A, Ciancio BC, Lopez-Chavarrias V, Mølbak K, Pebody R, Pedzinski B, et al. Influenza-related deaths-available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe. Euro Surveill (2012) 17(18):20162. doi:10.2807/ese.17.18.20162-en
9. Nunes B, Viboud C, Machado A, Ringholz C, Rebelo-de-Andrade H, Nogueira P, et al. Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS One (2011) 6(6):e20661. doi:10.1371/journal.pone.0020661
10. Nunes B, Natário I, Carvalho ML. Time series methods for obtaining excess mortality attributable to influenza epidemics. Stat Methods Med Res (2011) 20:331-45. doi:10.1177/0962280209340201
11. Yang L, Ma S, Chen PY, He JF, Chan KP, Chow A, et al. Influenza associated mortality in the subtropics and tropics: results from three Asian cities. Vaccine (2011) 29(48):8909-14. doi:10.1016/j.vaccine.2011.09.071
12. Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Med (2006) 3(4):e89. doi:10.1371/journal.pmed.0030089
13. Alonso WJ, Viboud C, Simonsen L, Hirano EW, Daufenbach LZ, Miller MA. Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol (2007) 165(12):1434-42. doi:10.1093/aje/kwm012
14. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep (1963) 78(6):494-506. doi:10.2307/4591848
15. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med (2005) 165(3):265-72. doi:10.1001/archinte.165.3.265
16. López-Cuadrado MS, Jiménez-Jorge S, Savulescu AC, Larrauri A. Influenza-related mortality in Spain, 1999-2005. Gac Sanit (2012) 26:325-9. doi:10.1016/j.gaceta.2011.09.033
17. Thomas RE. Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness? Vaccine (2014) 32:2143-9. doi:10.1016/j.vaccine.2014.02.059
18. Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses (2009) 3:37-49. doi:10.1111/j.1750-2659.2009.00073.x
19. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 289(2):179-86. doi:10.1001/jama.289.2.179
20. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol (2002) 37(2-3):427-39. doi:10.1016/S0531-5565(01)00210-8
21. Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One (2012) 7(9):e45051. doi:10.1371/journal.pone.0045051
22. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 320(5874):340-6. doi:10.1126/science.1154137
23. Su S, Chaves SS, Perez A, D'Mello T, Kirley PD, Yousey-Hindes K, et al. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin Infect Dis (2014) 59(2):252-5. doi:10.1093/cid/ciu269
24. Souza MDFMD, Widdowson MA, Alencar AP, Gawryszewski VP, Aziz-Baumgartner E, Palekar R, et al. Trends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic. Bull World Health Organ (2013) 91(7):525-32. doi:10.2471/BLT.12.116871
25. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 12:687-95. doi:10.1016/S1473-3099(12)70121-4
26. La Gruta NL, Turner SJ. T cell mediated immunity to influenza: mechanisms of viral control. Trends Immunol (2014) 35(8):396-402. doi:10.1016/j.it.2014.06.004
27. McElhaney JE, Kuchel GA, Zhou X, Swain SL, Haynes L. T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines. Front Immunol (2016) 7:41. doi:10.3389/fimmu.2016.00041
28. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol (2007) 85:85-92. doi:10.1038/sj.icb.7100026
29. Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 12:1203-7. doi:10.1038/nm1477
30. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis (2009) 9(10):601-10. doi:10.1016/S1473-3099(09)70233-6
31. Harskamp RE, van Ginkel MW. Acute respiratory tract infections: a potential trigger for the acute coronary syndrome. Ann Med (2008) 40:121-8. doi:10.1080/07853890701753672
32. Madjid M, Awan I, Ali M, Frazier L, Casscells W. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther (2005) 5:91-6. doi:10.1517/14712598.5.1.91
33. Drell DW, Notkins AL. Multiple immunological abnormalities in patients with type 1 (insulin dependent) diabetes mellitus. Diabetologia (1987) 30:132-43. doi:10.1007/BF00274217
34. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care (2000) 23(1):95-108. doi:10.2337/diacare.23.1.95
35. Green HK, Andrews N, Fleming D, Zambon M, Pebody R. Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic. PLoS One (2013) 8(12):e79360. doi:10.1371/journal.pone.0079360
36. Van Kerkhove MD, Vandemaele KAH, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med (2011) 8:e1001053. doi:10.1371/journal.pmed.1001053
37. Oliveira WK, Carmo EH, Penna GO, Kuchenbecker RS, Santos HB, Araujo WN, et al. Pandemic H1N1 influenza in Brazil: analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI). Euro Surveill (2009) 14(42):19362. doi:10.2807/ese.14.42.19362-en
38. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 178(1):53-60. doi:10.1086/515616
39. Simonsen L, Viboud C, Taylor RJ, Miller MA. Epidemiology of influenza and its control. In: Rappuoli R, Del Giudice G, editors. Influenza Vaccines for the Future. 2nd ed. Basel: Springer (2011). p. 27-55
40. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 445(7125):319. doi:10.1038/nature05495
41. Gao R, Bhatnagar J, Blau DM, Greer P, Rollin DC, Denison AM, et al. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am J Pathol (2013) 83(4):1258-68. doi:10.1016/j.ajpath.2013.06.023
42. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 361(20):1945-52. doi:10.1056/NEJMoa0906453
43. Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J (2008) 5(1):40. doi:10.1186/1743-422X-5-40
44. Chi SX, Bolar TV, Zhao P, Tam JS, Rappaport R, Cheng S. Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003. J Clin Microbiol (2005) 43:6130-2. doi:10.1128/JCM.43.12.6130-6132.2005
45. Oliveira TFDMS, Yokosawa J, Motta FC, Siqueira MM, da Silveira HL, Queiróz DAO. Molecular characterization of influenza viruses collected from young children in Uberlandia, Brazil-from 2001 to 2010. BMC Infect Dis (2015) 15(1):71. doi:10.1186/s12879-015-0817-z
46. Straliotto SM, Gregianini TS, Baccin TG, Motta FC, Siqueira M. Virus influenza detectados no estado do Rio Grande do Sul durante, 2006 e 2007. Bol Saúde (2009) 23(1):57-62
47. Center for Disease Control and Prevention. Influenza activity-United States and worldwide, 2007-08 season. MMWR Recomm Rep (2008) 2757(25):692-7
48. Simonsen L, Clarke J, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health (1997) 87(2):1944-50. doi:10.2105/AJPH.87.12.1944
49. Foppa IM, Cheng PY, Reynolds SB, Shay DK, Carias C, Bresee JS, et al. Deaths averted by influenza vaccination in the US during the seasons 2005/06 through 2013/14. Vaccine (2015) 33(26):3003-9. doi:10.1016/j.vaccine.2015.02.042